Dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. The Fc component of etanercept contains the CH2 domain, the CH3 domain and hinge region, but not the CH1 domain of IgG1. Etanercept is produced by recombinant DNA technolo...
Etanercept is indicated for the treatment of moderately to severely active rheumatoid arthritis in adults and in chronic moderate to severe plaque psoriasis in patients 4 years of age and older. It is also used to manage signs and symptoms of polyarticular idiopathic arthritis and Juvenile Psoriatic Arthritis in those aged 2 years and older. Etanercept is al...
IRCCS Istituto Giannina Gaslini, Genova, GE, Italy
Rutgers, Robert Wood Johnson Medical School, Clinical Research Center, New Brunswick, New Jersey, United States
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Universitatsklinikum Carl Gustav Carcus Dresden, Dresden, Germany
Universitatsklinikum Frankfurt, Frankfurt, Germany
Kirk Barber Reseach Inc., Calgary, Alberta, Canada
University of Nebraska Medical Center, Omaha, Nebraska, United States
Instituto Medico CER, Bs As, Argentina
Orchidpharmed PK/PD site, Tehrān, Tehran, Iran, Islamic Republic of
AI Centrum Medyczne, Poznań, Poland
PRA Health Sciences, Groningen, Netherlands
University of Alberta, Edmonton, Alberta, Canada
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.